ESC 365 - Is it possible the use of sacubitril/valsartan in HFrEF and hemodialysis?

HFA Premium Access

Is it possible the use of sacubitril/valsartan in HFrEF and hemodialysis?

Session: Poster Session 2 - Basic Science - Chronic Heart Failure – Pathophysiology and Mechanisms

Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)

Speaker: Mr J. Morgado (Huelva, ES)

Event: Heart Failure 2018

Congress Presentation

Add to my library

About the speaker

Mr Jose Morgado

Hospital Juan Ramon Jimenez, Huelva (Spain)

1 presentation

0 follower

46 more presentations in this session

Increased expression of galectin-3 in the interstitium of left ventricular myocardium of dogs with chronic heart failure

Speaker: Professor H. Sabbah (Detroit, US)

Necroptosis in post-ischemic heart failure: causality of cardiac dysfunction and remodeling?

Speaker: Mr M. Lichy (Bratislava, SK)

Genetic diagnosis in transthyretin cardiac amyloidosis - a single Polish centre experience

Speaker: Doctor M. Gawor (Warsaw, PL)

Differential endomyocardial expression of SGLT1 in idiopathic dilated cardiomyopathy patients with and without diabetes mellitus.

Speaker: Doctor M. Vanderheyden (Aalst, BE)

Decreased longitudinal left ventricular contraction after acute myocardial infarction in a porcine model revealing the opportunity for new treatments with mechanical circulatory support devices

Speaker: Mr J. Berg (Lund, SE)

Access the full session

Poster Session 2 - Basic Science - Chronic Heart Failure – Pathophysiology and Mechanisms

Speakers: Mr J. Morgado, Professor H. Sabbah, Mr M. Lichy, Doctor M. Gawor, Doctor M. Vanderheyden...

About the event

Heart Failure 2018

26 May - 29 May 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources